BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005;206:260-276. [PMID: 16048554 DOI: 10.1111/j.0105-2896.2005.00291.x] [Cited by in Crossref: 362] [Cited by in F6Publishing: 345] [Article Influence: 21.3] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka K. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2008;2:193-196. [PMID: 19072354 DOI: 10.1586/17474124.2.2.193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
2 Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41:10-16. [PMID: 16501852 DOI: 10.1007/s00535-005-1744-3] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 6.1] [Reference Citation Analysis]
3 Shin JS, Cho EJ, Choi HE, Seo JH, An HJ, Park HJ, Cho YW, Lee KT. Anti-inflammatory effect of a standardized triterpenoid-rich fraction isolated from Rubus coreanus on dextran sodium sulfate-induced acute colitis in mice and LPS-induced macrophages. J Ethnopharmacol 2014;158 Pt A:291-300. [PMID: 25446582 DOI: 10.1016/j.jep.2014.10.044] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
4 Xiang JY, Wu LG, Huang XL, Zhang M, Pen L, Ouyan Q, Gan HT. Amelioration of murine dextran sulfate sodium-induced colitis by nuclear factor-kappaB decoy oligonucleotides. Am J Surg 2009;197:797-805. [PMID: 18926515 DOI: 10.1016/j.amjsurg.2008.04.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
5 Lin Z, Poritz L, Franke A, Li TY, Ruether A, Byrnes KA, Wang Y, Gebhard AW, MacNeill C, Thomas NJ, Schreiber S, Koltun WA. Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women. Dig Dis Sci 2010;55:739-46. [PMID: 19294505 DOI: 10.1007/s10620-009-0782-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
6 Spasova DS, Surh CD. Blowing on embers: commensal microbiota and our immune system. Front Immunol 2014;5:318. [PMID: 25120539 DOI: 10.3389/fimmu.2014.00318] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
7 Maloy KJ. Induction and regulation of inflammatory bowel disease in immunodeficient mice by distinct CD4+ T-cell subsets. Methods Mol Biol 2007;380:327-35. [PMID: 17876102 DOI: 10.1007/978-1-59745-395-0_19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
8 Andrei M, Nicolaie T, Stoicescu A, Teiușanu A, Gologan Ș, Diculescu M. Intestinal Microbiome, Small Intestinal Bacterial Overgrowth and Inflammatory Bowel Diseases - What are the Connections? Curr Health Sci J 2015;41:197-203. [PMID: 30534422 DOI: 10.12865/CHSJ.41.03.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Liu Z, Wilson-welder JH, Hostetter JM, Jergens AE, Wannemuehler MJ. Prophylactic treatment with Hypoxis hemerocallidea corm (African potato) methanolic extract ameliorates Brachyspira hyodysenteriae -induced murine typhlocolitis. Exp Biol Med (Maywood) 2010;235:222-30. [DOI: 10.1258/ebm.2009.009269] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
10 Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, Bere P, Sarraj B, Khan MW, Pakanati KC. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci USA. 2011;108 Suppl 1:4623-4630. [PMID: 21282652 DOI: 10.1073/pnas.1005066107] [Cited by in Crossref: 164] [Cited by in F6Publishing: 162] [Article Influence: 14.9] [Reference Citation Analysis]
11 Wakimoto S, Nakayama-Imaohji H, Ichimura M, Morita H, Hirakawa H, Hayashi T, Yasutomo K, Kuwahara T. PhoB regulates the survival of Bacteroides fragilis in peritoneal abscesses. PLoS One 2013;8:e53829. [PMID: 23342014 DOI: 10.1371/journal.pone.0053829] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kelsall B. Innate and adaptive mechanisms to control of pathological intestinal inflammation. J Pathol 2008;214:242-59. [DOI: 10.1002/path.2286] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
13 Schmitz JM, McCracken VJ, Dimmitt RA, Lorenz RG. Expression of CXCL15 (Lungkine) in murine gastrointestinal, urogenital, and endocrine organs. J Histochem Cytochem 2007;55:515-24. [PMID: 17242461 DOI: 10.1369/jhc.6A7121.2007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
14 Walsh D, McCarthy J, O'Driscoll C, Melgar S. Pattern recognition receptors--molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev 2013;24:91-104. [PMID: 23102645 DOI: 10.1016/j.cytogfr.2012.09.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
15 Franzke A, Hunger JK, Dittmar KEJ, Ganser A, Buer J. Regulatory T-cells in the control of immunological diseases. Ann Hematol 2006;85:747-58. [DOI: 10.1007/s00277-006-0117-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
16 Vanhooren V, Vandenbroucke RE, Dewaele S, Van Hamme E, Haigh JJ, Hochepied T, Libert C. Mice overexpressing β-1,4-Galactosyltransferase I are resistant to TNF-induced inflammation and DSS-induced colitis. PLoS One 2013;8:e79883. [PMID: 24339869 DOI: 10.1371/journal.pone.0079883] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
17 Kovarik JJ, Tillinger W, Hofer J, Hölzl MA, Heinzl H, Saemann MD, Zlabinger GJ. Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD. Eur J Clin Invest. 2011;41:291-298. [PMID: 21070220 DOI: 10.1111/j.1365-2362.2010.02407.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
18 Schoeb TR, Bullard DC. Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:1558-65. [PMID: 22294506 DOI: 10.1002/ibd.22892] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
19 Wu C, Xu Z, Gai R, Huang K. Matrine ameliorates spontaneously developed colitis in interleukin-10-deficient mice. Int Immunopharmacol. 2016;36:256-262. [PMID: 27179305 DOI: 10.1016/j.intimp.2016.04.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
20 Asquith MJ, Stauffer P, Davin S, Mitchell C, Lin P, Rosenbaum JT. Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis. Arthritis Rheumatol 2016;68:2151-62. [PMID: 26992013 DOI: 10.1002/art.39681] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 12.2] [Reference Citation Analysis]
21 Selber-Hnatiw S, Rukundo B, Ahmadi M, Akoubi H, Al-Bizri H, Aliu AF, Ambeaghen TU, Avetisyan L, Bahar I, Baird A, Begum F, Ben Soussan H, Blondeau-Éthier V, Bordaries R, Bramwell H, Briggs A, Bui R, Carnevale M, Chancharoen M, Chevassus T, Choi JH, Coulombe K, Couvrette F, D'Abreau S, Davies M, Desbiens MP, Di Maulo T, Di Paolo SA, Do Ponte S, Dos Santos Ribeiro P, Dubuc-Kanary LA, Duncan PK, Dupuis F, El-Nounou S, Eyangos CN, Ferguson NK, Flores-Chinchilla NR, Fotakis T, Gado Oumarou H D M, Georgiev M, Ghiassy S, Glibetic N, Grégoire Bouchard J, Hassan T, Huseen I, Ibuna Quilatan MF, Iozzo T, Islam S, Jaunky DB, Jeyasegaram A, Johnston MA, Kahler MR, Kaler K, Kamani C, Karimian Rad H, Konidis E, Konieczny F, Kurianowicz S, Lamothe P, Legros K, Leroux S, Li J, Lozano Rodriguez ME, Luponio-Yoffe S, Maalouf Y, Mantha J, McCormick M, Mondragon P, Narayana T, Neretin E, Nguyen TTT, Niu I, Nkemazem RB, O'Donovan M, Oueis M, Paquette S, Patel N, Pecsi E, Peters J, Pettorelli A, Poirier C, Pompa VR, Rajen H, Ralph RO, Rosales-Vasquez J, Rubinshtein D, Sakr S, Sebai MS, Serravalle L, Sidibe F, Sinnathurai A, Soho D, Sundarakrishnan A, Svistkova V, Ugbeye TE, Vasconcelos MS, Vincelli M, Voitovich O, Vrabel P, Wang L, Wasfi M, Zha CY, Gamberi C. Human Gut Microbiota: Toward an Ecology of Disease. Front Microbiol 2017;8:1265. [PMID: 28769880 DOI: 10.3389/fmicb.2017.01265] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 13.4] [Reference Citation Analysis]
22 Espaillat MP, Snider AJ, Qiu Z, Channer B, Coant N, Schuchman EH, Kew RR, Sheridan BS, Hannun YA, Obeid LM. Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment. FASEB J 2018;32:2339-53. [PMID: 29259036 DOI: 10.1096/fj.201700585R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
23 Cho EJ, Shin JS, Chung KS, Lee YS, Cho YW, Baek NI, Chung HG, Lee KT. Arvelexin inhibits colonic inflammation by suppression of NF-κB activation in dextran sulfate sodium-induced mice and TNF-α-induced colonic epithelial cells. J Agric Food Chem 2012;60:7398-407. [PMID: 22794033 DOI: 10.1021/jf3009553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
24 Kim DH, Cheon JH. Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Netw 2017;17:25-40. [PMID: 28261018 DOI: 10.4110/in.2017.17.1.25] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 25.8] [Reference Citation Analysis]
25 Newman KM, Vaughn BP. Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.19.02610-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, Braun J, Targan SR. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008;135:552-67. [PMID: 18598698 DOI: 10.1053/j.gastro.2008.04.037] [Cited by in Crossref: 180] [Cited by in F6Publishing: 179] [Article Influence: 12.9] [Reference Citation Analysis]
27 Cho JY, Kim HY, Kim SK, Park JHY, Lee HJ, Chun HS. β-Caryophyllene attenuates dextran sulfate sodium-induced colitis in mice via modulation of gene expression associated mainly with colon inflammation. Toxicol Rep 2015;2:1039-45. [PMID: 28962446 DOI: 10.1016/j.toxrep.2015.07.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
28 Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1-17. [PMID: 18297430 DOI: 10.1007/s00535-007-2111-3] [Cited by in Crossref: 116] [Cited by in F6Publishing: 116] [Article Influence: 8.3] [Reference Citation Analysis]
29 Speck KE, Garrison AP, Rigby RJ, von Allmen DC, Lund PK, Helmrath MA. Inflammation enhances resection-induced intestinal adaptive growth in IL-10 null mice. J Surg Res 2011;168:62-9. [PMID: 20074747 DOI: 10.1016/j.jss.2009.09.051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
30 Heylen M, Ruyssers NE, Gielis EM, Vanhomwegen E, Pelckmans PA, Moreels TG, De Man JG, De Winter BY. Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease. Pharmacol Ther 2014;143:153-67. [PMID: 24603369 DOI: 10.1016/j.pharmthera.2014.02.011] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
31 Izumi R, Azuma K, Izawa H, Morimoto M, Nagashima M, Osaki T, Tsuka T, Imagawa T, Ito N, Okamoto Y, Saimoto H, Ifuku S. Chitin nanofibrils suppress skin inflammation in atopic dermatitis-like skin lesions in NC/Nga mice. Carbohydr Polym 2016;146:320-7. [PMID: 27112880 DOI: 10.1016/j.carbpol.2016.03.068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
32 Ballard D, Abraham C, Cho J, Zhao H. Pathway analysis comparison using Crohn's disease genome wide association studies. BMC Med Genomics 2010;3:25. [PMID: 20584322 DOI: 10.1186/1755-8794-3-25] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
33 Pascual V, Dieli-Crimi R, López-Palacios N, Bodas A, Medrano LM, Núñez C. Inflammatory bowel disease and celiac disease: Overlaps and differences. World J Gastroenterol 2014; 20(17): 4846-4856 [PMID: 24803796 DOI: 10.3748/wjg.v20.i17.4846] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
34 Ostanin DV, Furr KL, Pavlick KP, Gray L, Kevil CG, Shukla D, D'Souza D, Hoffman JM, Grisham MB. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G1706-14. [PMID: 17332469 DOI: 10.1152/ajpgi.00573.2006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
35 Yu W, Su X, Chen W, Tian X, Zhang K, Guo G, Zhou L, Zeng T, Han B. Three types of gut bacteria collaborating to improve Kui Jie’an enema treat DSS-induced colitis in mice. Biomedicine & Pharmacotherapy 2019;113:108751. [DOI: 10.1016/j.biopha.2019.108751] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
36 Martín R, Chain F, Miquel S, Motta JP, Vergnolle N, Sokol H, Langella P. Using murine colitis models to analyze probiotics-host interactions. FEMS Microbiol Rev 2017;41:S49-70. [PMID: 28830096 DOI: 10.1093/femsre/fux035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
37 Kang SS, Bloom SM, Norian LA, Geske MJ, Flavell RA, Stappenbeck TS, Allen PM. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med. 2008;5:e41. [PMID: 18318596 DOI: 10.1371/journal.pmed.0050041] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 6.7] [Reference Citation Analysis]
38 Andoh A, Imaeda H, Aomatsu T, Inatomi O, Bamba S, Sasaki M, Saito Y, Tsujikawa T, Fujiyama Y. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol. 2011;46:479-486. [PMID: 21253779 DOI: 10.1007/s00535-010-0368-4] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
39 Engelhardt KR, Grimbacher B. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr Top Microbiol Immunol. 2014;380:1-18. [PMID: 25004811 DOI: 10.1007/978-3-662-43492-5_1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
40 Zhou R, Chang Y, Liu J, Chen M, Wang H, Huang M, Liu S, Wang X, Zhao Q. JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease. Front Immunol. 2017;8:781. [PMID: 28725226 DOI: 10.3389/fimmu.2017.00781] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
41 Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One. 2009;4:e7056. [PMID: 19756155 DOI: 10.1371/journal.pone.0007056] [Cited by in Crossref: 177] [Cited by in F6Publishing: 162] [Article Influence: 13.6] [Reference Citation Analysis]
42 Ritchie LE, Sturino JM, Carroll RJ, Rooney LW, Azcarate-Peril MA, Turner ND. Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis. FEMS Microbiol Ecol 2015;91:fiv008. [PMID: 25764457 DOI: 10.1093/femsec/fiv008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
43 Lin Z, John G, Hegarty JP, Berg A, Yu W, Wang Y, Kelly AA, Peterson BZ, Poritz LS, Floros J, Koltun WA. Genetic variants and monoallelic expression of surfactant protein-D in inflammatory bowel disease. Ann Hum Genet 2011;75:559-68. [PMID: 21790524 DOI: 10.1111/j.1469-1809.2011.00662.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
44 Grimm V, Radulovic K, Riedel CU. Colonization of C57BL/6 Mice by a Potential Probiotic Bifidobacterium bifidum Strain under Germ-Free and Specific Pathogen-Free Conditions and during Experimental Colitis. PLoS One. 2015;10:e0139935. [PMID: 26439388 DOI: 10.1371/journal.pone.0139935] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
45 Hundorfean G, Neurath MF, Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 2010;14:2393-403. [PMID: 19878366 DOI: 10.1111/j.1582-4934.2009.00959.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
46 Weigmann B. Induction of Colitis in Mice (T-Cell Transfer Model). In: Waisman A, Becher B, editors. T-Helper Cells. New York: Springer; 2014. pp. 143-51. [DOI: 10.1007/978-1-4939-1212-4_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Landuyt AE, Klocke BJ, Duck LW, Kemp KM, Muir RQ, Jennings MS, Blum SI, Tse HM, Lee G, Morrow CD, Elson CO, Maynard CL. ICOS ligand and IL-10 synergize to promote host-microbiota mutualism. Proc Natl Acad Sci U S A 2021;118:e2018278118. [PMID: 33753483 DOI: 10.1073/pnas.2018278118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Ward NL, Phillips CD, Nguyen DD, Shanmugam NK, Song Y, Hodin R, Shi HN, Cherayil BJ, Goldstein AM. Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis. Inflamm Bowel Dis 2016;22:2328-40. [PMID: 27607336 DOI: 10.1097/MIB.0000000000000914] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
49 Elson CO. Animal Models of Experimental IBD: Have They Taught Enough or Do We Need More? Inflammatory Bowel Diseases 2006;12:S5. [DOI: 10.1097/00054725-200610003-00011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Shahir NM, Wang JR, Wolber EA, Schaner MS, Frank DN, Ir D, Robertson CE, Chaumont N, Sadiq TS, Koruda MJ, Rahbar R, Nix BD, Newberry RD, Sartor RB, Sheikh SZ, Furey TS. Crohn's Disease Differentially Affects Region-Specific Composition and Aerotolerance Profiles of Mucosally Adherent Bacteria. Inflamm Bowel Dis 2020;26:1843-55. [PMID: 32469069 DOI: 10.1093/ibd/izaa103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Liu Z, Cao AT, Cong Y. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin Cancer Biol. 2013;23:543-552. [PMID: 24071482 DOI: 10.1016/j.semcancer.2013.09.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
52 Sun X, Yamada H, Yoshihara K, Awaya A, Yoshikai Y. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice. International Immunopharmacology 2007;7:928-36. [DOI: 10.1016/j.intimp.2007.02.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
53 Hering NA, Fromm M, Schulzke JD. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol. 2012;590:1035-1044. [PMID: 22219336 DOI: 10.1113/jphysiol.2011.224568] [Cited by in Crossref: 159] [Cited by in F6Publishing: 153] [Article Influence: 15.9] [Reference Citation Analysis]
54 Tomasello G, Bellavia M, Damiano G, Gioviale MC, Lo Monte AI. Possible relation between gut microflora composition and oncogenic risk: is stimulation of inflammation the one ring of connection? Reviews in Medical Microbiology 2012;23:52-7. [DOI: 10.1097/mrm.0b013e328353f49c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
55 Chung CY, Park YL, Kim N, Oh HH, Myung DS, Kim JS, Cho SB, Lee WS, Kim HS, Ahn BW, Joo YE. Rice prolamin extract ameliorates acute murine colitis by inhibiting nuclear factor-kappa B and modulating intestinal apoptosis and cell proliferation. Clin Exp Immunol 2014;178:537-47. [PMID: 25098704 DOI: 10.1111/cei.12431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
56 Abdel Hadi L, Di Vito C, Riboni L. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces. Mediators Inflamm 2016;2016:3827684. [PMID: 26880864 DOI: 10.1155/2016/3827684] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
57 Yang GY, Taboada S, Liao J. Inflammatory bowel disease: a model of chronic inflammation-induced cancer. Methods Mol Biol. 2009;511:193-233. [PMID: 19347299 DOI: 10.1007/978-1-59745-447-6_9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
58 Damman CJ, Miller SI, Surawicz CM, Zisman TL. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012;107:1452-9. [PMID: 23034604 DOI: 10.1038/ajg.2012.93] [Cited by in Crossref: 135] [Cited by in F6Publishing: 120] [Article Influence: 13.5] [Reference Citation Analysis]
59 Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis. 2007;8:171-178. [PMID: 17970872 DOI: doi:10.1111/j.1751-2980.2007.00310.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006;203:2473-2483. [PMID: 17030949 DOI: 10.1084/jem.20061099] [Cited by in Crossref: 605] [Cited by in F6Publishing: 584] [Article Influence: 37.8] [Reference Citation Analysis]
61 D'Haens GR, Sartor RB, Silverberg MS, Petersson J, Rutgeerts P. Future directions in inflammatory bowel disease management. J Crohns Colitis. 2014;8:726-734. [PMID: 24742736 DOI: 10.1016/j.crohns.2014.02.025] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 8.3] [Reference Citation Analysis]
62 Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol. 2008;153:263-270. [PMID: 17906675 DOI: 10.1038/sj.bjp.0707486] [Cited by in Crossref: 157] [Cited by in F6Publishing: 148] [Article Influence: 10.5] [Reference Citation Analysis]
63 Li S, Takasu C, Lau H, Robles L, Vo K, Farzaneh T, Vaziri ND, Stamos MJ, Ichii H. Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways. Antioxidants (Basel) 2020;9:E354. [PMID: 32344663 DOI: 10.3390/antiox9040354] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
64 Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729-1737. [PMID: 21530739 DOI: 10.1053/j.gastro.2011.02.012] [Cited by in Crossref: 328] [Cited by in F6Publishing: 315] [Article Influence: 29.8] [Reference Citation Analysis]
65 Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, Matsui T, Fujiyama Y, Matsumoto T. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J Gastroenterol. 2012;47:1298-1307. [PMID: 22576027 DOI: 10.1007/s00535-012-0605-0] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
66 Rodrigues DM, Sousa AJ, Johnson-Henry KC, Sherman PM, Gareau MG. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. J Infect Dis. 2012;206:99-109. [PMID: 22430833 DOI: 10.1093/infdis/jis177] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
67 Ishimaru N, Yamada A, Kohashi M, Arakaki R, Takahashi T, Izumi K, Hayashi Y. Development of inflammatory bowel disease in Long-Evans Cinnamon rats based on CD4+CD25+Foxp3+ regulatory T cell dysfunction. J Immunol. 2008;180:6997-7008. [PMID: 18453622 DOI: 10.4049/jimmunol.180.10.6997] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
68 Westbrook AM, Szakmary A, Schiestl RH. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res. 2010;705:40-59. [PMID: 20298806 DOI: 10.1016/j.mrrev.2010.03.001] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
69 Chen X, Feng BS, Zheng PY, Liao XQ, Chong J, Tang SG, Yang PC. Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine. Am J Pathol. 2008;173:1647-1656. [PMID: 18974296 DOI: 10.2353/ajpath.2008.080487] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
70 Eden K. Adoptive Transfer Colitis. Methods Mol Biol 2019;1960:207-14. [PMID: 30798534 DOI: 10.1007/978-1-4939-9167-9_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Chang AH, Parsonnet J. Role of bacteria in oncogenesis. Clin Microbiol Rev 2010;23:837-57. [PMID: 20930075 DOI: 10.1128/CMR.00012-10] [Cited by in Crossref: 86] [Cited by in F6Publishing: 52] [Article Influence: 7.2] [Reference Citation Analysis]
72 Kilian E, Suchodolski JS, Hartmann K, Mueller RS, Wess G, Unterer S. Long-term effects of canine parvovirus infection in dogs. PLoS One 2018;13:e0192198. [PMID: 29547647 DOI: 10.1371/journal.pone.0192198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
73 Holmkvist P, Pool L, Hägerbrand K, Agace WW, Rivollier A. IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness. Eur J Immunol 2016;46:1371-82. [PMID: 27062602 DOI: 10.1002/eji.201545957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
74 Espaillat MP, Kew RR, Obeid LM. Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Adv Biol Regul 2017;63:140-55. [PMID: 27866974 DOI: 10.1016/j.jbior.2016.11.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
75 Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis. 2009;15:341-352. [PMID: 18942757 DOI: 10.1002/ibd.20753] [Cited by in Crossref: 449] [Cited by in F6Publishing: 453] [Article Influence: 34.5] [Reference Citation Analysis]
76 Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4:337-349. [PMID: 18854238 DOI: 10.1016/j.chom.2008.09.009] [Cited by in Crossref: 1119] [Cited by in F6Publishing: 1066] [Article Influence: 79.9] [Reference Citation Analysis]
77 Almeida Cde S, Andrade-Oliveira V, Câmara NO, Jacysyn JF, Faquim-Mauro EL. Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice. PLoS One 2015;10:e0121427. [PMID: 25853847 DOI: 10.1371/journal.pone.0121427] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
78 Gutiérrez A, Francés R, Amorós A, Zapater P, Garmendia M, Ndongo M, Caño R, Jover R, Such J, Pérez-mateo M. Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease: . Inflammatory Bowel Diseases 2009;15:508-14. [DOI: 10.1002/ibd.20806] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
79 Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434. [PMID: 17653185 DOI: 10.1038/nature06005] [Cited by in Crossref: 2640] [Cited by in F6Publishing: 2548] [Article Influence: 176.0] [Reference Citation Analysis]
80 Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2016; 22(7): 2195-2205 [PMID: 26900284 DOI: 10.3748/wjg.v22.i7.2195] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 78] [Article Influence: 14.0] [Reference Citation Analysis]
81 Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20(1): 6-21 [PMID: 24415853 DOI: 10.3748/wjg.v20.i1.6] [Cited by in CrossRef: 269] [Cited by in F6Publishing: 252] [Article Influence: 33.6] [Reference Citation Analysis]
82 Ghandikota S, Sharma M, Jegga AG. Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19. Patterns (N Y) 2021;2:100247. [PMID: 33842903 DOI: 10.1016/j.patter.2021.100247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 John G, Hegarty JP, Yu W, Berg A, Pastor DM, Kelly AA, Wang Y, Poritz LS, Schreiber S, Koltun WA, Lin Z. NKX2-3 variant rs11190140 is associated with IBD and alters binding of NFAT. Mol Genet Metab 2011;104:174-9. [PMID: 21803625 DOI: 10.1016/j.ymgme.2011.06.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
84 Frol'ová L, Smetana K Jr, Borovská D, Kitanovicová A, Klimesová K, Janatková I, Malícková K, Lukás M, Drastich P, Benes Z, Tucková L, Manning JC, André S, Gabius HJ, Tlaskalová-Hogenová H. Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? Inflamm Res 2009;58:503-12. [PMID: 19271150 DOI: 10.1007/s00011-009-0016-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
85 Araki M, Shinzaki S, Yamada T, Arimitsu S, Komori M, Shibukawa N, Mukai A, Nakajima S, Kinoshita K, Kitamura S, Murayama Y, Ogawa H, Yasunaga Y, Oshita M, Fukui H, Masuda E, Tsujii M, Hiyama S, Inoue T, Iijima H, Takehara T. Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease. J Gastroenterol 2017;52:1149-57. [PMID: 28168321 DOI: 10.1007/s00535-017-1313-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
86 Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat–zucman S, Paul P, Gornet J, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A. CD4+NKG2D+ T Cells in Crohn’s Disease Mediate Inflammatory and Cytotoxic Responses Through MICA Interactions. Gastroenterology 2007;132:2346-58. [DOI: 10.1053/j.gastro.2007.03.025] [Cited by in Crossref: 135] [Cited by in F6Publishing: 137] [Article Influence: 9.0] [Reference Citation Analysis]
87 Olivier I, Theodorou V, Valet P, Castan-laurell I, Ferrier L, Eutamène H. Modifications of mesenteric adipose tissue during moderate experimental colitis in mice. Life Sciences 2014;94:1-7. [DOI: 10.1016/j.lfs.2013.09.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
88 Takemura A, Egawa T, Tanaka T, Kuramoto T, Hayashi T, Ishihara A. Effects of Exposure to Mild Hyperbaric Oxygen on DSS-Induced Colonic Inflammation and Diarrhea in Rats. J Inflamm Res 2019;12:293-9. [PMID: 31754309 DOI: 10.2147/JIR.S220586] [Reference Citation Analysis]
89 Mestecky J, Russell MW, Elson CO. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J Immunol 2007;179:5633-8. [PMID: 17947632 DOI: 10.4049/jimmunol.179.9.5633] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 7.3] [Reference Citation Analysis]
90 Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 2009;31:377-88. [PMID: 19766081 DOI: 10.1016/j.immuni.2009.09.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
91 Schrenk D. Dietary fiber, low-molecular-weight food constituents and colo-rectal inflammation in animal models - A review. Mol Nutr Food Res 2009;53:1281-8. [DOI: 10.1002/mnfr.200800576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
92 Elson CO, Cong Y, Weaver CT, Schoeb TR, Mcclanahan TK, Fick RB, Kastelein RA. Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice. Gastroenterology 2007;132:2359-70. [DOI: 10.1053/j.gastro.2007.03.104] [Cited by in Crossref: 326] [Cited by in F6Publishing: 313] [Article Influence: 21.7] [Reference Citation Analysis]
93 Mohamadzadeh M, Owen JL. Reprogramming intestinal immunity is the answer to induced pathogenic inflammation. Immunotherapy 2011;3:1415-7. [PMID: 22091675 DOI: 10.2217/imt.11.140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Kobayashi K, Qiao SW, Yoshida M, Baker K, Lencer WI, Blumberg RS. An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice. Gastroenterology. 2009;137:1746-56.e1. [PMID: 19664634 DOI: 10.1053/j.gastro.2009.07.059] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
95 Zhu X, Liu Z, Liu JQ, Zhu J, Zhang J, Davis JP, Chu J, Yu J, Zhou J, Li MS, Bai XF. Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells. J Leukoc Biol 2016;100:403-11. [PMID: 27106672 DOI: 10.1189/jlb.3A1215-540R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
96 Klaassen MAY, Imhann F, Collij V, Fu J, Wijmenga C, Zhernakova A, Dijkstra G, Festen EAM, Gacesa R, Vich Vila A, Weersma RK. Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations. J Crohns Colitis 2019;13:1439-49. [PMID: 31066440 DOI: 10.1093/ecco-jcc/jjz077] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
97 Wehkamp J, Chu H, Shen B, Feathers RW, Kays RJ, Lee SK, Bevins CL. Paneth cell antimicrobial peptides: Topographical distribution and quantification in human gastrointestinal tissues. FEBS Letters 2006;580:5344-50. [DOI: 10.1016/j.febslet.2006.08.083] [Cited by in Crossref: 117] [Cited by in F6Publishing: 113] [Article Influence: 7.3] [Reference Citation Analysis]
98 Schultz M. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1012-1018. [PMID: 18240278 DOI: 10.1002/ibd.20377] [Cited by in Crossref: 144] [Cited by in F6Publishing: 138] [Article Influence: 10.3] [Reference Citation Analysis]
99 Andoh A, Kobayashi T, Kuzuoka H, Tsujikawa T, Suzuki Y, Hirai F, Matsui T, Nakamura S, Matsumoto T, Fujiyama Y. Characterization of gut microbiota profiles by disease activity in patients with Crohn's disease using data mining analysis of terminal restriction fragment length polymorphisms. Biomed Rep 2014;2:370-3. [PMID: 24748976 DOI: 10.3892/br.2014.252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
100 Watanabe D, Kamada N. Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease. Front Med 2022;9:826240. [DOI: 10.3389/fmed.2022.826240] [Reference Citation Analysis]
101 Heylen M, Deleye S, De Man JG, Ruyssers NE, Vermeulen W, Stroobants S, Pelckmans PA, Moreels TG, Staelens S, De Winter BY. Colonoscopy and μPET/CT are valid techniques to monitor inflammation in the adoptive transfer colitis model in mice. Inflamm Bowel Dis. 2013;19:967-976. [PMID: 23407045 DOI: 10.1097/mib.0b013e3182802c7c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
102 Kuchler U, Luvizuto ER, Muñoz F, Hofbauer J, Watzek G, Gruber R. Bone healing around titanium implants in two rat colitis models. Clin Oral Implants Res 2013;24:224-9. [PMID: 22509782 DOI: 10.1111/j.1600-0501.2012.02454.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
103 Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009;296:G135-46. [PMID: 19033538 DOI: 10.1152/ajpgi.90462.2008] [Cited by in Crossref: 259] [Cited by in F6Publishing: 261] [Article Influence: 18.5] [Reference Citation Analysis]
104 Yoshimi K, Tanaka T, Takizawa A, Kato M, Hirabayashi M, Mashimo T, Serikawa T, Kuramoto T. Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat. Cancer Sci 2009;100:2022-7. [PMID: 19694754 DOI: 10.1111/j.1349-7006.2009.01287.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
105 Frolova L, Drastich P, Rossmann P, Klimesova K, Tlaskalova-Hogenova H. Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem 2008;56:267-74. [PMID: 18040078 DOI: 10.1369/jhc.7A7303.2007] [Cited by in Crossref: 102] [Cited by in F6Publishing: 65] [Article Influence: 6.8] [Reference Citation Analysis]
106 De Vroey B, De Cassan C, Gower-Rousseau C, Colombel JF. Editorial: Antibiotics earlier, IBD later? Am J Gastroenterol 2010;105:2693-6. [PMID: 21131935 DOI: 10.1038/ajg.2010.396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
107 Davaatseren M, Hwang JT, Park JH, Kim MS, Wang S, Sung MJ. Allyl isothiocyanate ameliorates angiogenesis and inflammation in dextran sulfate sodium-induced acute colitis. PLoS One 2014;9:e102975. [PMID: 25051185 DOI: 10.1371/journal.pone.0102975] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
108 Barone M, Chain F, Sokol H, Brigidi P, Bermúdez-Humarán LG, Langella P, Martín R. A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain. Front Microbiol 2018;9:565. [PMID: 29636738 DOI: 10.3389/fmicb.2018.00565] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
109 Collison LW, Vignali DA. Interleukin-35: odd one out or part of the family? Immunol Rev 2008;226:248-62. [PMID: 19161429 DOI: 10.1111/j.1600-065X.2008.00704.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 98] [Article Influence: 13.3] [Reference Citation Analysis]
110 An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, Braun J, Xia L. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med 2007;204:1417-29. [PMID: 17517967 DOI: 10.1084/jem.20061929] [Cited by in Crossref: 212] [Cited by in F6Publishing: 206] [Article Influence: 14.1] [Reference Citation Analysis]
111 Moon C, Stupp GS, Su AI, Wolan DW. Metaproteomics of Colonic Microbiota Unveils Discrete Protein Functions among Colitic Mice and Control Groups. Proteomics 2018;18. [PMID: 29319931 DOI: 10.1002/pmic.201700391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
112 Park SY, Ku SK, Lee ES, Kim JA. 1,3-Diphenylpropenone ameliorates TNBS-induced rat colitis through suppression of NF-κB activation and IL-8 induction. Chem Biol Interact 2012;196:39-49. [PMID: 22410118 DOI: 10.1016/j.cbi.2012.02.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
113 McAleer JP, Kolls JK. Contributions of the intestinal microbiome in lung immunity. Eur J Immunol. 2018;48:39-49. [PMID: 28776643 DOI: 10.1002/eji.201646721] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 15.6] [Reference Citation Analysis]
114 Li H, Gong Y, Xie Y, Sun Q, Li Y. Clostridium butyricum protects the epithelial barrier by maintaining tight junction protein expression and regulating microflora in a murine model of dextran sodium sulfate-induced colitis. Scandinavian Journal of Gastroenterology 2018;53:1031-42. [DOI: 10.1080/00365521.2016.1192678] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
115 Bartel G, Weiss I, Turetschek K, Schima W, Püspök A, Waldhoer T, Gasche C. Ingested matter affects intestinal lesions in Crohn’s disease. Inflamm Bowel Dis. 2008;14:374-382. [PMID: 17932967 DOI: 10.1002/ibd.20295] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
116 de Graaf AA, Venema K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol 2008;53:73-168. [PMID: 17707144 DOI: 10.1016/S0065-2911(07)53002-X] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
117 Yang H, Kozicky L, Saferali A, Fung SY, Afacan N, Cai B, Falsafi R, Gill E, Liu M, Kollmann TR, Hancock RE, Sly LM, Turvey SE. Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. Biomaterials 2016;111:90-102. [PMID: 27728817 DOI: 10.1016/j.biomaterials.2016.09.032] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
118 Wine E, Ossa JC, Gray-Owen SD, Sherman PM. Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol. 2009;9:180. [PMID: 19709415 DOI: 10.1186/1471-2180-9-180] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
119 Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, Pochart P, Doré J, Marteau P. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006;24 Suppl 3:11-8. [PMID: 16961738 DOI: 10.1111/j.1365-2036.2006.03053.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 7.5] [Reference Citation Analysis]
120 Elson CO. From cheese to pharma: a designer probiotic for IBD. Clin Gastroenterol Hepatol 2006;4:836-7. [PMID: 16829347 DOI: 10.1016/j.cgh.2006.05.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
121 Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010;8:564-577. [PMID: 20622892 DOI: 10.1038/nrmicro2403] [Cited by in Crossref: 223] [Cited by in F6Publishing: 226] [Article Influence: 18.6] [Reference Citation Analysis]
122 Xue X, Cao AT, Cao X, Yao S, Carlsen ED, Soong L, Liu CG, Liu X, Liu Z, Duck LW. Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression. Eur J Immunol. 2014;44:673-682. [PMID: 24293139 DOI: 10.1002/eji.201343717] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
123 Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, Nakajima H, Karow M, Takeuchi T. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis. 2010;16:1017-1028. [PMID: 19834971 DOI: 10.1002/ibd.21151] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 7.1] [Reference Citation Analysis]
124 Matricon J, Barnich N, Ardid D. Immunopathogenesis of inflammatory bowel disease. Self Nonself. 2010;1:299-309. [PMID: 21487504 DOI: 10.4161/self.1.4.13560] [Cited by in Crossref: 122] [Cited by in F6Publishing: 117] [Article Influence: 15.3] [Reference Citation Analysis]
125 Koboziev I, Karlsson F, Ostanin DV, Gray L, Davidson M, Zhang S, Grisham MB. Role of LFA-1 in the activation and trafficking of T cells: implications in the induction of chronic colitis. Inflamm Bowel Dis 2012;18:2360-70. [PMID: 22488891 DOI: 10.1002/ibd.22947] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
126 Cong Y, Wang L, Konrad A, Schoeb T, Elson CO. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells. Eur J Immunol 2009;39:3134-46. [PMID: 19839007 DOI: 10.1002/eji.200939052] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
127 Azuma K, Ifuku S. Nanofibers based on chitin: a new functional food. Pure and Applied Chemistry 2016;88:605-19. [DOI: 10.1515/pac-2016-0504] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
128 O’Sullivan S, Gilmer JF, Medina C. Matrix metalloproteinases in inflammatory bowel disease: an update. Mediators Inflamm. 2015;2015:964131. [PMID: 25948887 DOI: 10.1155/2015/964131] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
129 Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol. 2010;28:623-667. [PMID: 20192812 DOI: 10.1146/annurev-immunol-030409-101330] [Cited by in Crossref: 363] [Cited by in F6Publishing: 340] [Article Influence: 30.3] [Reference Citation Analysis]
130 Veltkamp C, Ruhwald R, Veltkamp R, Giese T, Stremmel W. Regulatory CD4+ CD25+ T cells prevent thymic dysfunction in experimental chronic colitis. Scand J Immunol 2007;66:636-44. [PMID: 18021363 DOI: 10.1111/j.1365-3083.2007.02015.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Shah N, Kammermeier J, Elawad M, Glocker EO. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep. 2012;12:373-379. [PMID: 22890722 DOI: 10.1007/s11882-012-0286-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
132 Fukata M, Breglio K, Chen A, Vamadevan AS, Goo T, Hsu D, Conduah D, Xu R, Abreu MT. The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease. J Immunol 2008;180:1886-94. [PMID: 18209086 DOI: 10.4049/jimmunol.180.3.1886] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 6.9] [Reference Citation Analysis]
133 Schäffler H, Kaschitzki A, Alberts C, Bodammer P, Bannert K, Köller T, Warnke P, Kreikemeyer B, Lamprecht G. Alterations in the mucosa-associated bacterial composition in Crohn’s disease: a pilot study. Int J Colorectal Dis 2016;31:961-71. [DOI: 10.1007/s00384-016-2548-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
134 Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006;12:641-650. [PMID: 16804402 DOI: 10.1097/01.mib.0000225332.83861.5f] [Cited by in Crossref: 82] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
135 Feng T, Wang L, Schoeb TR, Elson CO, Cong Y. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med 2010;207:1321-32. [PMID: 20498021 DOI: 10.1084/jem.20092253] [Cited by in Crossref: 155] [Cited by in F6Publishing: 156] [Article Influence: 12.9] [Reference Citation Analysis]
136 Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009;139:485-498. [PMID: 19836068 DOI: 10.1016/j.cell.2009.09.033] [Cited by in Crossref: 2802] [Cited by in F6Publishing: 2621] [Article Influence: 215.5] [Reference Citation Analysis]
137 Greer JB, O'Keefe SJ. Microbial induction of immunity, inflammation, and cancer. Front Physiol. 2011;1:168. [PMID: 21423403 DOI: 10.3389/fphys.2010.00168] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
138 Zhou Y, Ni H, Li M, Sanzari JK, Diffenderfer ES, Lin L, Kennedy AR, Weissman D. Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activation. PLoS One 2012;7:e44329. [PMID: 23028522 DOI: 10.1371/journal.pone.0044329] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
139 Jena G, Trivedi PP, Sandala B. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radic Res. 2012;46:1339-1345. [PMID: 22856328 DOI: 10.3109/10715762.2012.717692] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
140 Sarra M, Monteleone I, Stolfi C, Fantini MC, Sileri P, Sica G, Tersigni R, Macdonald TT, Pallone F, Monteleone G. Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm Bowel Dis. 2010;16:1332-1339. [PMID: 20186935 DOI: 10.1002/ibd.21238] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
141 Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, Suchodolski JS. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol. 2008;66:579-589. [PMID: 18647355 DOI: 10.1111/j.1574-6941.2008.00556.x] [Cited by in Crossref: 139] [Cited by in F6Publishing: 117] [Article Influence: 9.9] [Reference Citation Analysis]
142 Steinhart AH, Tolomiczenko G. IBD 2009: emerging research frontiers on the path to a cure. Can J Gastroenterol 2010;24:557-65. [PMID: 21152461 DOI: 10.1155/2010/795780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066-2078. [PMID: 19923578 DOI: 10.1056/nejmra0804647] [Cited by in Crossref: 1689] [Cited by in F6Publishing: 900] [Article Influence: 129.9] [Reference Citation Analysis]
144 Zhang J, Romero J, Chan A, Goss J, Stucka S, Cross J, Chamberlain B, Varoglu M, Chandonnet H, Ryan D, Lippa B. Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters 2015;25:3661-4. [DOI: 10.1016/j.bmcl.2015.06.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
145 Chang S, Parker GA, Kleinschmidt SE, Olsen GW, Ley CA, Taiwo OA. A Pathology Review of the Lower Gastrointestinal Tract in Relation to Ulcerative Colitis in Rats and Cynomolgus Macaques Treated With Ammonium Perfluorooctanoate. Toxicol Pathol 2020;48:593-602. [PMID: 32186254 DOI: 10.1177/0192623320911606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Holleran G, Lopetuso L, Petito V, Graziani C, Ianiro G, McNamara D, Gasbarrini A, Scaldaferri F. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. Int J Mol Sci. 2017;18. [PMID: 28934123 DOI: 10.3390/ijms18102020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
147 Ng SC, Benjamin JL, McCarthy NE, Hedin CR, Koutsoumpas A, Plamondon S, Price CL, Hart AL, Kamm MA, Forbes A, Knight SC, Lindsay JO, Whelan K, Stagg AJ. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis. 2011;17:2027-2037. [PMID: 21910165 DOI: 10.1002/ibd.21590] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
148 Wick EC, Rabizadeh S, Albesiano E, Wu X, Wu S, Chan J, Rhee KJ, Ortega G, Huso DL, Pardoll D, Housseau F, Sears CL. Stat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis. Inflamm Bowel Dis 2014;20:821-34. [PMID: 24704822 DOI: 10.1097/MIB.0000000000000019] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
149 Casey KM, Johnson AL, Hunrath MN, Fraser JK, McCowan NC, Wasson K, Doty RA, Griffey SM, Imai DM. Proliferative Typhlocolitis With Multinucleated Giant Cells: A Nonspecific Enteropathy in Immunodeficient Sentinel Mice. Vet Pathol 2019;56:157-68. [PMID: 30222063 DOI: 10.1177/0300985818798106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
150 Elson CO, Cong Y. Host-microbiota interactions in inflammatory bowel disease. Gut Microbes 2012;3:332-44. [PMID: 22572873 DOI: 10.4161/gmic.20228] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
151 Pelletier AM, Venkataramana S, Miller KG, Bennett BM, Nair DG, Lourenssen S, Blennerhassett MG. Neuronal nitric oxide inhibits intestinal smooth muscle growth. Am J Physiol Gastrointest Liver Physiol. 2010;298:G896-G907. [PMID: 20338922 DOI: 10.1152/ajpgi.00259.2009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
152 Hu S, Chen M, Wang Y, Wang Z, Pei Y, Fan R, Liu X, Wang L, Zhou J, Zheng S, Zhang T, Lin Y, Zhang M, Tao R, Zhong J. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile. PLoS One 2016;11:e0154564. [PMID: 27128484 DOI: 10.1371/journal.pone.0154564] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
153 Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541-546. [PMID: 17406617 DOI: 10.1038/nprot.2007.41] [Cited by in Crossref: 964] [Cited by in F6Publishing: 964] [Article Influence: 64.3] [Reference Citation Analysis]
154 Viladomiu M, Hontecillas R, Yuan L, Lu P, Bassaganya-Riera J. Nutritional protective mechanisms against gut inflammation. J Nutr Biochem. 2013;24:929-939. [PMID: 23541470 DOI: 10.1016/j.jnutbio.2013.01.006] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 10.2] [Reference Citation Analysis]
155 Ballester V, Guo X, Vendrell R, Haritunians T, Klomhaus AM, Li D, McGovern DP, Rotter JI, Torres EA, Taylor KD. Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico. PLoS One. 2014;9:e108204. [PMID: 25259511 DOI: 10.1371/journal.pone.0108204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
156 Steenholdt C, Andresen L, Pedersen G, Hansen A, Brynskov J. Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2009;44:195-204. [DOI: 10.1080/00365520802495529] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
157 Pouyet L, Roisin-Bouffay C, Clément A, Millet V, Garcia S, Chasson L, Issaly N, Rostan A, Hofman P, Naquet P, Galland F. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model. Inflamm Bowel Dis 2010;16:96-104. [PMID: 19572375 DOI: 10.1002/ibd.21031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
158 Elshal MF, Aldahlawi AM, Saadah OI, McCoy JP. Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells. Int J Mol Sci 2015;16:28998-9010. [PMID: 26690123 DOI: 10.3390/ijms161226143] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
159 Song YA, Park YL, Kim KY, Chung CY, Lee GH, Cho DH, Ki HS, Park KJ, Cho SB, Lee WS. Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis. BMC Complement Altern Med. 2011;11:91. [PMID: 21989142 DOI: 10.1186/1472-6882-11-91] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
160 Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology. 2007;133:1327-1339. [PMID: 17919503 DOI: 10.1053/j.gastro.2007.08.032] [Cited by in Crossref: 121] [Cited by in F6Publishing: 103] [Article Influence: 8.1] [Reference Citation Analysis]
161 Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci. 2006;1072:28-38. [PMID: 17057188 DOI: 10.1196/annals.1326.008] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 4.8] [Reference Citation Analysis]
162 Onken JE, Greer PK, Calingaert B, Hale LP. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin Immunol 2008;126:345-52. [PMID: 18160345 DOI: 10.1016/j.clim.2007.11.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
163 Grisham MB. Do different animal models of IBD serve different purposes?: . Inflammatory Bowel Diseases 2008;14:S132-3. [DOI: 10.1097/00054725-200810001-00064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
164 Vezza T, Rodríguez-nogales A, Algieri F, Utrilla M, Rodriguez-cabezas M, Galvez J. Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients 2016;8:211. [DOI: 10.3390/nu8040211] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 18.8] [Reference Citation Analysis]
165 Valatas V, Vakas M, Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 2013;305:G763-G785. [PMID: 23989010 DOI: 10.1152/ajpgi.00004.2013] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
166 Sarin R, Abraham C. CD18 is required for optimal lymphopenia-induced proliferation of mouse T cells. Am J Physiol Gastrointest Liver Physiol 2012;303:G851-60. [PMID: 22821945 DOI: 10.1152/ajpgi.00520.2011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
167 Glocker E, Grimbacher B. Inflammatory bowel disease: is it a primary immunodeficiency? Cell Mol Life Sci. 2012;69:41-48. [PMID: 21997382 DOI: 10.1007/s00018-011-0837-9] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
168 Gutiérrez A, Zapater P, Juanola O, Sempere L, García M, Laveda R, Martínez A, Scharl M, González-navajas JM, Such J, Wiest R, Rogler G, Francés R. Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn’s Disease. American Journal of Gastroenterology 2016;111:529-40. [DOI: 10.1038/ajg.2016.8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
169 Shiga H, Kajiura T, Shinozaki J, Takagi S, Kinouchi Y, Takahashi S, Negoro K, Endo K, Kakuta Y, Suzuki M, Shimosegawa T. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Digestive and Liver Disease 2012;44:736-42. [DOI: 10.1016/j.dld.2012.04.014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
170 Shima H, Masuda S, Date Y, Shino A, Tsuboi Y, Kajikawa M, Inoue Y, Kanamoto T, Kikuchi J. Exploring the Impact of Food on the Gut Ecosystem Based on the Combination of Machine Learning and Network Visualization. Nutrients 2017;9:E1307. [PMID: 29194366 DOI: 10.3390/nu9121307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
171 Gadaleta RM, Garcia-Irigoyen O, Moschetta A. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD). Curr Protoc Mouse Biol 2017;7:13-28. [PMID: 28252200 DOI: 10.1002/cpmo.20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
172 Azuma K, Osaki T, Minami S, Okamoto Y. Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides. J Funct Biomater 2015;6:33-49. [PMID: 25594943 DOI: 10.3390/jfb6010033] [Cited by in Crossref: 142] [Cited by in F6Publishing: 118] [Article Influence: 20.3] [Reference Citation Analysis]
173 Zhou W, Cao Q, Peng Y, Zhang QJ, Castrillon DH, DePinho RA, Liu ZP. FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. Gastroenterology. 2009;137:1403-1414. [PMID: 19560465 DOI: 10.1053/j.gastro.2009.06.049] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
174 Walrath T, Dyamenahalli KU, Hulsebus HJ, McCullough RL, Idrovo JP, Boe DM, McMahan RH, Kovacs EJ. Age-related changes in intestinal immunity and the microbiome. J Leukoc Biol 2021;109:1045-61. [PMID: 33020981 DOI: 10.1002/JLB.3RI0620-405RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Tong M, Li X, Wegener Parfrey L, Roth B, Ippoliti A, Wei B, Borneman J, McGovern DP, Frank DN, Li E. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One. 2013;8:e80702. [PMID: 24260458 DOI: 10.1371/journal.pone.0080702] [Cited by in Crossref: 108] [Cited by in F6Publishing: 105] [Article Influence: 12.0] [Reference Citation Analysis]
176 Török H, Göke B, Konrad A. Pharmacogenetics of Crohn’s disease. Pharmacogenomics 2008;9:881-93. [DOI: 10.2217/14622416.9.7.881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
177 Takedatsu H, Taylor KD, Mei L, McGovern DP, Landers CJ, Gonsky R, Cong Y, Vasiliauskas EA, Ippoliti A, Elson CO, Rotter JI, Targan SR. Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation. Gut 2009;58:60-7. [PMID: 18832525 DOI: 10.1136/gut.2008.156422] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
178 Negroni A, Costanzo M, Vitali R, Superti F, Bertuccini L, Tinari A, Minelli F, Di Nardo G, Nuti F, Pierdomenico M, Cucchiara S, Stronati L. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:913-924. [PMID: 21994005 DOI: 10.1002/ibd.21899] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
179 Gove ME, Pini M, Fayad R, Cabay RJ, Fantuzzi G. Adiponectin deficiency modulates adhesion molecules expression and cytokine production but does not affect disease severity in the transfer model of colitis. Cytokine 2009;47:119-25. [PMID: 19520591 DOI: 10.1016/j.cyto.2009.05.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
180 Yang JM, Fu Y, Zou KF, Liu XJ, Men L. Changes in follicular helper T cells in immune complex and TNBS induced colitis in mice. Shijie Huaren Xiaohua Zazhi 2014; 22(23): 3452-3458 [DOI: 10.11569/wcjd.v22.i23.3452] [Reference Citation Analysis]
181 Ménager-Marcq I, Pomié C, Romagnoli P, van Meerwijk JP. CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology. 2006;131:1775-1785. [PMID: 17087950 DOI: 10.1053/j.gastro.2006.09.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 4.8] [Reference Citation Analysis]
182 Piñero P, Juanola O, Gutiérrez A, Zapater P, Giménez P, Steinert A, Sempere L, González-navajas JM, Niess JH, Francés R. IL26 modulates cytokine response and anti-TNF consumption in Crohn’s disease patients with bacterial DNA. J Mol Med 2017;95:1227-36. [DOI: 10.1007/s00109-017-1585-6] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
183 Janeczko S, Atwater D, Bogel E, Greiter-Wilke A, Gerold A, Baumgart M, Bender H, McDonough PL, McDonough SP, Goldstein RE. The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel disease. Vet Microbiol. 2008;128:178-193. [PMID: 18054447 DOI: 10.1016/j.vetmic.2007.10.014] [Cited by in Crossref: 120] [Cited by in F6Publishing: 101] [Article Influence: 8.0] [Reference Citation Analysis]
184 Clarke K, Chintanaboina J. Allergic and Immunologic Perspectives of Inflammatory Bowel Disease. Clin Rev Allergy Immunol 2019;57:179-93. [PMID: 29754190 DOI: 10.1007/s12016-018-8690-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
185 Buer J, Westendorf AM, Zeng A, He F, Hansen W, Probst-kepper M. Mechanisms of Central and Peripheral T-Cell Tolerance: An Update. Transfus Med Hemother 2005;32:384-99. [DOI: 10.1159/000089128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
186 Claes IJ, De Keersmaecker SC, Vanderleyden J, Lebeer S. Lessons from probiotic-host interaction studies in murine models of experimental colitis. Mol Nutr Food Res 2011;55:1441-53. [PMID: 21796777 DOI: 10.1002/mnfr.201100139] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
187 Cording S, Fleissner D, Heimesaat MM, Bereswill S, Loddenkemper C, Uematsu S, Akira S, Hamann A, Huehn J. Commensal microbiota drive proliferation of conventional and Foxp3(+) regulatory CD4(+) T cells in mesenteric lymph nodes and Peyer's patches. Eur J Microbiol Immunol (Bp) 2013;3:1-10. [PMID: 24265914 DOI: 10.1556/EuJMI.3.2013.1.1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
188 Williams CS, Bradley AM, Chaturvedi R, Singh K, Piazuelo MB, Chen X, McDonough EM, Schwartz DA, Brown CT, Allaman MM, Coburn LA, Horst SN, Beaulieu DB, Choksi YA, Washington MK, Williams AD, Fisher MA, Zinkel SS, Peek RM Jr, Wilson KT, Hiebert SW. MTG16 contributes to colonic epithelial integrity in experimental colitis. Gut 2013;62:1446-55. [PMID: 22833394 DOI: 10.1136/gutjnl-2011-301439] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
189 Hou YC, Liu JJ, Pai MH, Tsou SS, Yeh SL. Alanyl-glutamine administration suppresses Th17 and reduces inflammatory reaction in dextran sulfate sodium-induced acute colitis. Int Immunopharmacol. 2013;17:1-8. [PMID: 23721689 DOI: 10.1016/j.intimp.2013.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
190 Weingarden AR, Vaughn BP. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes. 2017;8:238-252. [PMID: 28609251 DOI: 10.1080/19490976.2017.1290757] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 16.0] [Reference Citation Analysis]
191 Netzel-Arnett S, Buzza MS, Shea-Donohue T, Désilets A, Leduc R, Fasano A, Bugge TH, Antalis TM. Matriptase protects against experimental colitis and promotes intestinal barrier recovery. Inflamm Bowel Dis 2012;18:1303-14. [PMID: 22081509 DOI: 10.1002/ibd.21930] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
192 Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. J Gastroenterol. 2010;45:571-583. [PMID: 20213337 DOI: 10.1007/s00535-010-0219-3] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 9.7] [Reference Citation Analysis]
193 Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol. 2008;8:458-466. [PMID: 18500230 DOI: 10.1038/nri2340] [Cited by in Crossref: 631] [Cited by in F6Publishing: 596] [Article Influence: 45.1] [Reference Citation Analysis]
194 Kawagoe T, Takeuchi O, Takabatake Y, Kato H, Isaka Y, Tsujimura T, Akira S. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol 2009;10:965-72. [PMID: 19668221 DOI: 10.1038/ni.1771] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 9.2] [Reference Citation Analysis]
195 Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC, Kärre K, Pettersson S, Greicius G. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis. 2012;33:1231-1238. [PMID: 22461519 DOI: 10.1093/carcin/bgs137] [Cited by in Crossref: 128] [Cited by in F6Publishing: 117] [Article Influence: 12.8] [Reference Citation Analysis]
196 Albright CA, Sartor RB, Tonkonogy SL. Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria. Immunol Lett 2009;123:77-87. [PMID: 19428554 DOI: 10.1016/j.imlet.2009.02.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
197 Zhang H, Zheng Y, Pan Y, Lin C, Wang S, Yan Z, Lu L, Ge G, Li J, Zeng YA, Chen J. A mutation that blocks integrin α4β7 activation prevents adaptive immune-mediated colitis without increasing susceptibility to innate colitis. BMC Biol 2020;18:64. [PMID: 32522281 DOI: 10.1186/s12915-020-00784-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Gutiérrez A, Scharl M, Sempere L, Holler E, Zapater P, Almenta I, González-Navajas JM, Such J, Wiest R, Rogler G, Francés R. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease. Gut 2014;63:272-80. [PMID: 23376290 DOI: 10.1136/gutjnl-2012-303557] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
199 Endharti AT, Okuno Y, Shi Z, Misawa N, Toyokuni S, Ito M, Isobe K, Suzuki H. CD8+CD122+ regulatory T cells (Tregs) and CD4+ Tregs cooperatively prevent and cure CD4+ cell-induced colitis. J Immunol 2011;186:41-52. [PMID: 21098236 DOI: 10.4049/jimmunol.1000800] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
200 Wuensch T, Ullrich S, Schulz S, Chamaillard M, Schaltenberg N, Rath E, Goebel U, Sartor RB, Prager M, Büning C, Bugert P, Witt H, Haller D, Daniel H. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation. Inflamm Bowel Dis 2014;20:671-84. [PMID: 24583477 DOI: 10.1097/01.MIB.0000443336.71488.08] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
201 Schirbel A, Fiocchi C. Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010;11:266-276. [PMID: 20883422 DOI: 10.1111/j.1751-2980.2010.00449.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
202 Sharpton T, Lyalina S, Luong J, Pham J, Deal EM, Armour C, Gaulke C, Sanjabi S, Pollard KS. Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice. mSystems 2017;2:e00036-17. [PMID: 28904997 DOI: 10.1128/mSystems.00036-17] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
203 Azuma YT, Nishiyama K, Matsuo Y, Kuwamura M, Morioka A, Nakajima H, Takeuchi T. PPARα contributes to colonic protection in mice with DSS-induced colitis. Int Immunopharmacol 2010;10:1261-7. [PMID: 20650341 DOI: 10.1016/j.intimp.2010.07.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
204 Hoffmann M, Kim SC, Sartor RB, Haller D. Enterococcus faecalis strains differentially regulate Alix/AIP1 protein expression and ERK 1/2 activation in intestinal epithelial cells in the context of chronic experimental colitis. J Proteome Res 2009;8:1183-92. [PMID: 19166300 DOI: 10.1021/pr800785m] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
205 Shen C, Landers CJ, Derkowski C, Elson CO, Targan SR. Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease. Inflamm Bowel Dis 2008;14:1641-51. [PMID: 18825772 DOI: 10.1002/ibd.20645] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
206 van der Steen L, Tuk CW, Bakema JE, Kooij G, Reijerkerk A, Vidarsson G, Bouma G, Kraal G, de Vries HE, Beelen RH, van Egmond M. Immunoglobulin A: FcαRI Interactions Induce Neutrophil Migration Through Release of Leukotriene B4. Gastroenterology 2009;137:2018-2029.e3. [DOI: 10.1053/j.gastro.2009.06.047] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
207 Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: A hypothesis on intimate interplay at the intestinal mucosa. Seminars in Immunology 2007;19:70-83. [DOI: 10.1016/j.smim.2007.04.002] [Cited by in Crossref: 262] [Cited by in F6Publishing: 240] [Article Influence: 17.5] [Reference Citation Analysis]
208 Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H, Fellermann K, Ganz T, Stange EF, Bevins CL. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA. 2005;102:18129-18134. [PMID: 16330776 DOI: 10.1073/pnas.0505256102] [Cited by in Crossref: 671] [Cited by in F6Publishing: 641] [Article Influence: 39.5] [Reference Citation Analysis]
209 Schwanke RC, Marcon R, Bento AF, Calixto JB. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease. Eur J Pharmacol 2016;785:156-64. [PMID: 26325092 DOI: 10.1016/j.ejphar.2015.08.050] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
210 Chen X, Zuo Q, Hai Y, Sun XJ. Lactulose: An indirect antioxidant ameliorating inflammatory bowel disease by increasing hydrogen production. Medical Hypotheses 2011;76:325-7. [DOI: 10.1016/j.mehy.2010.09.026] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
211 Borenshtein D, Nambiar PR, Groff EB, Fox JG, Schauer DB. Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect Immun 2007;75:3271-81. [PMID: 17470543 DOI: 10.1128/IAI.01810-06] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
212 Grisham MB. Do different animal models of IBD serve different purposes? Inflamm Bowel Dis 2008;14 Suppl 2:S132-3. [PMID: 18816751 DOI: 10.1002/ibd.20682] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
213 Hudak JE, Alvarez D, Skelly A, von Andrian UH, Kasper DL. Illuminating vital surface molecules of symbionts in health and disease. Nat Microbiol 2017;2:17099. [PMID: 28650431 DOI: 10.1038/nmicrobiol.2017.99] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 8.6] [Reference Citation Analysis]
214 Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A, Jin C, Wunderlich C, Wunderlich T, Eisenbarth SC, Flavell RA. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:9862-9867. [PMID: 23696660 DOI: 10.1073/pnas.1307575110] [Cited by in Crossref: 192] [Cited by in F6Publishing: 178] [Article Influence: 21.3] [Reference Citation Analysis]
215 Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. 2008;125:145-153. [PMID: 18798918 DOI: 10.1111/j.1365-2567.2008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
216 Zhang T, Ding C, Zhao M, Dai X, Yang J, Li Y, Gu L, Wei Y, Gong J, Zhu W, Li N, Li J. Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice. Nutrients 2016;8:E728. [PMID: 27886121 DOI: 10.3390/nu8120728] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
217 Azuma K, Osaki T, Kurozumi S, Kiyose M, Tsuka T, Murahata Y, Imagawa T, Itoh N, Minami S, Sato K, Okamoto Y. Anti-inflammatory effects of orally administered glucosamine oligomer in an experimental model of inflammatory bowel disease. Carbohydr Polym. 2015;115:448-456. [PMID: 25439918 DOI: 10.1016/j.carbpol.2014.09.012] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
218 Juanola O, Moratalla A, Gutiérrez A, Sempere L, Zapater P, Giménez P, Almenta I, Peiró G, González-navajas JM, Such JF, Francés R. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn’s disease. J Gastroenterol 2015;50:758-68. [DOI: 10.1007/s00535-014-1020-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
219 Azuma K, Osaki T, Ifuku S, Saimoto H, Morimoto M, Takashima O, Tsuka T, Imagawa T, Okamoto Y, Minami S. Anti-inflammatory effects of cellulose nanofiber made from pear in inflammatory bowel disease model. Bioactive Carbohydrates and Dietary Fibre 2014;3:1-10. [DOI: 10.1016/j.bcdf.2013.11.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
220 Cho J. Finding inflammatory bowel disease genes will lead to a cure. Can J Gastroenterol 2006;20:641-2. [PMID: 17066153 DOI: 10.1155/2006/561643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
221 Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res. 2012;56:524-535. [PMID: 22495981 DOI: 10.1002/mnfr.201100630] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 9.1] [Reference Citation Analysis]
222 Seno H, Miyoshi H, Brown SL, Geske MJ, Colonna M, Stappenbeck TS. Efficient colonic mucosal wound repair requires Trem2 signaling. Proc Natl Acad Sci U S A. 2009;106:256-261. [PMID: 19109436 DOI: 10.1073/pnas.0803343106] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 12.6] [Reference Citation Analysis]
223 Fu XY. STAT3 in immune responses and inflammatory bowel diseases. Cell Res. 2006;16:214-219. [PMID: 738222 DOI: 10.1038/sj.cr.7310029] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 1.2] [Reference Citation Analysis]
224 Dey M, Kuhn P, Ribnicky D, Premkumar V, Reuhl K, Raskin I. Dietary phenethylisothiocyanate attenuates bowel inflammation in mice. BMC Chem Biol 2010;10:4. [PMID: 20423518 DOI: 10.1186/1472-6769-10-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
225 Khan MW, Zadeh M, Bere P, Gounaris E, Owen J, Klaenhammer T, Mohamadzadeh M. Modulating intestinal immune responses by lipoteichoic acid-deficient Lactobacillus acidophilus. Immunotherapy 2012;4:151-61. [PMID: 22339459 DOI: 10.2217/imt.11.163] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
226 Zhong W, Xia Z, Hinrichs D, Rosenbaum JT, Wegmann KW, Meyrowitz J, Zhang Z. Hemin Exerts Multiple Protective Mechanisms and Attenuates Dextran Sulfate Sodium–induced Colitis. Journal of Pediatric Gastroenterology & Nutrition 2010;50:132-9. [DOI: 10.1097/mpg.0b013e3181c61591] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
227 Neumann D, Seifert R. The therapeutic potential of histamine receptor ligands in inflammatory bowel disease. Biochem Pharmacol 2014;91:12-7. [PMID: 24929116 DOI: 10.1016/j.bcp.2014.06.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
228 Håkansson Å, Bränning C, Adawi D, Molin G, Nyman M, Jeppsson B, Ahrné S. Blueberry husks, rye bran and multi-strain probiotics affect the severity of colitis induced by dextran sulphate sodium. Scandinavian Journal of Gastroenterology 2009;44:1213-25. [DOI: 10.1080/00365520903171268] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
229 Godoi DF, Cardoso CR, Ferraz DB, Provinciatto PR, Cunha FQ, Silva JS, Voltarelli JC. Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease. Bone Marrow Transplant. 2010;45:1562-1571. [PMID: 20228850 DOI: 10.1038/bmt.2010.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
230 Bousvaros A, Morley-Fletcher A, Pensabene L, Cucchiara S. Research and clinical challenges in paediatric inflammatory bowel disease. Dig Liver Dis. 2008;40:32-38. [PMID: 17996504 DOI: 10.1016/j.dld.2007.07.168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
231 Xia Y, Chen Y, Wang G, Yang Y, Song X, Xiong Z, Zhang H, Lai P, Wang S, Ai L. Lactobacillus plantarum AR113 alleviates DSS-induced colitis by regulating the TLR4/MyD88/NF-κB pathway and gut microbiota composition. Journal of Functional Foods 2020;67:103854. [DOI: 10.1016/j.jff.2020.103854] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
232 Urbanska AM, Bhathena J, Cherif S, Prakash S. Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis. Artif Cells Nanomed Biotechnol. 2016;44:1-11. [PMID: 25060720 DOI: 10.3109/21691401.2014.898647] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
233 Iweala OI, Nagler CR. Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora. Immunol Rev. 2006;213:82-100. [PMID: 16972898 DOI: 10.1111/j.1600-065x.2006.00431.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
234 Flanagan K, Modrusan Z, Cornelius J, Chavali A, Kasman I, Komuves L, Mo L, Diehl L. Intestinal epithelial cell up-regulation of LY6 molecules during colitis results in enhanced chemokine secretion. J Immunol 2008;180:3874-81. [PMID: 18322195 DOI: 10.4049/jimmunol.180.6.3874] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
235 Aomatsu T, Imaeda H, Fujimoto T, Takahashi K, Yoden A, Tamai H, Fujiyama Y, Andoh A. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease. Digestion. 2012;86:129-135. [PMID: 22846404 DOI: 10.1159/000339777] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
236 Comito D, Romano C. Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases. Int J Inflam. 2012;2012:687143. [PMID: 22685684 DOI: 10.1155/2012/687143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
237 Kajiura T, Takeda T, Sakata S, Sakamoto M, Hashimoto M, Suzuki H, Suzuki M, Benno Y. Change of Intestinal Microbiota with Elemental Diet and Its Impact on Therapeutic Effects in a Murine Model of Chronic Colitis. Dig Dis Sci 2009;54:1892-900. [DOI: 10.1007/s10620-008-0574-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
238 Azuma K, Osaki T, Ifuku S, Saimoto H, Tsuka T, Imagawa T, Okamoto Y, Minami S. α-Chitin nanofibrils improve inflammatory and fibrosis responses in inflammatory bowel disease mice model. Carbohydr Polym. 2012;90:197-200. [PMID: 24751030 DOI: 10.1016/j.carbpol.2012.05.023] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
239 Wu F, Dong F, Arendovich N, Zhang J, Huang Y, Kwon JH. Divergent influence of microRNA-21 deletion on murine colitis phenotypes. Inflamm Bowel Dis 2014;20:1972-85. [PMID: 25222661 DOI: 10.1097/MIB.0000000000000201] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
240 Jones-Hall YL, Grisham MB. Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease. Pathophysiology. 2014;21:267-288. [PMID: 24935242 DOI: 10.1016/j.pathophys.2014.05.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
241 Mangerich A, Dedon PC, Fox JG, Tannenbaum SR, Wogan GN. Chemistry meets biology in colitis-associated carcinogenesis. Free Radic Res. 2013;47:958-986. [PMID: 23926919 DOI: 10.3109/10715762.2013.832239] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
242 Chaniotou Z, Giannogonas P, Theoharis S, Teli T, Gay J, Savidge T, Koutmani Y, Brugni J, Kokkotou E, Pothoulakis C. Corticotropin-releasing factor regulates TLR4 expression in the colon and protects mice from colitis. Gastroenterology. 2010;139:2083-2092. [PMID: 20732324 DOI: 10.1053/j.gastro.2010.08.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
243 Silva MA. Intestinal dendritic cells and epithelial barrier dysfunction in Crohn’s disease. Inflamm Bowel Dis. 2009;15:436-453. [PMID: 18821596 DOI: 10.1002/ibd.20660] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
244 Hertogh GD, Aerssens J, Geboes KP, Geboes K. Evidence for the involvement of infectious agents in the pathogenesis of Crohn’s disease. World J Gastroenterol 2008; 14(6): 845-852 [PMID: 18240341 DOI: 10.3748/wjg.14.845] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
245 Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N, Pace NR, Li E. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:179-184. [PMID: 20839241 DOI: 10.1002/ibd.21339] [Cited by in Crossref: 406] [Cited by in F6Publishing: 376] [Article Influence: 33.8] [Reference Citation Analysis]
246 Nemoto Y, Kanai T, Takahara M, Oshima S, Okamoto R, Tsuchiya K, Matsumoto S, Watanabe M. Th1/Th17-Mediated Interstitial Pneumonia in Chronic Colitis Mice Independent of Intestinal Microbiota. J I 2013;190:6616-25. [DOI: 10.4049/jimmunol.1202930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
247 Lv J, Zhang Y, Tian Z, Liu F, Shi Y, Liu Y, Xia P. Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-κВ activation. Int J Biol Macromol 2017;98:723-9. [PMID: 28188801 DOI: 10.1016/j.ijbiomac.2017.02.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
248 Duck WL, Walter MR, Novak J, Kelly D, Tomasi M, Cong Y, Elson CO. Isolation of flagellated bacteria implicated in Crohnʼs disease: . Inflammatory Bowel Diseases 2007;13:1191-201. [DOI: 10.1002/ibd.20237] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 5.7] [Reference Citation Analysis]
249 Zhang DK, Cheng LN, Huang XL, Shi W, Xiang JY, Gan HT. Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -κB activation. Int J Colorectal Dis 2009;24:5-12. [DOI: 10.1007/s00384-008-0544-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
250 Janoff EN, Gustafson C, Frank DN. The world within: living with our microbial guests and guides. Transl Res 2012;160:239-45. [PMID: 22732305 DOI: 10.1016/j.trsl.2012.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
251 Harris NR, Whatley JR, Carter PR, Morgan GA, Grisham MB. Altered microvascular hemodynamics during the induction and perpetuation of chronic gut inflammation. Am J Physiol Gastrointest Liver Physiol 2009;296:G750-4. [PMID: 19221013 DOI: 10.1152/ajpgi.90702.2008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
252 Hsu CC, Piotrowski SL, Meeker SM, Smith KD, Maggio-Price L, Treuting PM. Histologic Lesions Induced by Murine Norovirus Infection in Laboratory Mice. Vet Pathol 2016;53:754-63. [PMID: 26792844 DOI: 10.1177/0300985815618439] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
253 Nemoto Y, Kanai T, Tohda S, Totsuka T, Okamoto R, Tsuchiya K, Nakamura T, Sakamoto N, Fukuda T, Miura O, Yagita H, Watanabe M. Negative feedback regulation of colitogenic CD4+ T cells by increased granulopoiesis: . Inflammatory Bowel Diseases 2008;14:1491-503. [DOI: 10.1002/ibd.20531] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
254 Ebert EC, Panja A, Das KM, Praveen R, Geng X, Rezac C, Bajpai M. Patients with inflammatory bowel disease may have a transforming growth factor-beta-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies. Clin Exp Immunol. 2009;155:65-71. [PMID: 19076830 DOI: 10.1111/j.1365-2249.2008.03802.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
255 Zhao Y, Yang Y, Zhang J, Wang R, Cheng B, Kalambhe D, Wang Y, Gu Z, Chen D, Wang B, Huang Y. Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases. Acta Pharm Sin B 2020;10:1966-76. [PMID: 33163347 DOI: 10.1016/j.apsb.2020.07.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
256 Stanghellini V, Barbara G, Cremon C, Cogliandro R, Antonucci A, Gabusi V, Frisoni C, De Giorgio R, Grasso V, Serra M. Gut microbiota and related diseases: clinical features. Intern Emerg Med. 2010;5 Suppl 1:S57-S63. [PMID: 20865476 DOI: 10.1007/s11739-010-0451-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
257 Hsu CC, Patil K, Seamons A, Brabb TL, Treuting PM, Paik J, Meeker SM, Maggio-Price L. Lack of Effect of Murine Norovirus Infection on the CD4+ CD45RBhigh T-cell Adoptive Transfer Mouse Model of Inflammatory Bowel Disease. Comp Med 2020;70:16-24. [PMID: 31937392 DOI: 10.30802/AALAS-CM-19-000009] [Reference Citation Analysis]
258 Becker C, Dornhoff H, Neufert C, Fantini MC, Wirtz S, Huebner S, Nikolaev A, Lehr HA, Murphy AJ, Valenzuela DM. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J Immunol. 2006;177:2760-2764. [PMID: 16920909 DOI: 10.4049/jimmunol.177.5.2760] [Cited by in Crossref: 170] [Cited by in F6Publishing: 167] [Article Influence: 10.6] [Reference Citation Analysis]
259 Parmar AS, Lappalainen M, Paavola-sakki P, Halme L, Färkkilä M, Turunen U, Kontula K, Aromaa A, Salomaa V, Peltonen L, Halfvarson J, Törkvist L, D'amato M, Saavalainen P, Einarsdottir E. Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients. Genes Immun 2012;13:474-80. [DOI: 10.1038/gene.2012.21] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
260 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
261 Zhu F, Liu XX, Fan H. Role of NLRP6 in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2019; 27(17): 1076-1082 [DOI: 10.11569/wcjd.v27.i17.1076] [Reference Citation Analysis]
262 Habtezion A, Toivola DM, Asghar MN, Kronmal GS, Brooks JD, Butcher EC, Omary MB. Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon. Proc Natl Acad Sci U S A 2011;108:1445-50. [PMID: 21220329 DOI: 10.1073/pnas.1010833108] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
263 Friedrich SK, Schmitz R, Bergerhausen M, Lang J, Cham LB, Duhan V, Häussinger D, Hardt C, Addo M, Prinz M, Asano K, Lang PA, Lang KS. Usp18 Expression in CD169+ Macrophages is Important for Strong Immune Response after Vaccination with VSV-EBOV. Vaccines (Basel) 2020;8:E142. [PMID: 32210083 DOI: 10.3390/vaccines8010142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
264 Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci. 2012;105:263-320. [PMID: 22137435 DOI: 10.1016/b978-0-12-394596-9.00009-3] [Cited by in Crossref: 136] [Cited by in F6Publishing: 76] [Article Influence: 13.6] [Reference Citation Analysis]
265 Nagahama K, Ogawa A, Shirane K, Shimomura Y, Sugimoto K, Mizoguchi A. Protein Kinase C θ Plays a Fundamental Role in Different Types of Chronic Colitis. Gastroenterology 2008;134:459-69. [DOI: 10.1053/j.gastro.2007.11.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
266 Nguyen DD, Maillard MH, Cotta-de-Almeida V, Mizoguchi E, Klein C, Fuss I, Nagler C, Mizoguchi A, Bhan AK, Snapper SB. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. Gastroenterology 2007;133:1188-97. [PMID: 17764675 DOI: 10.1053/j.gastro.2007.07.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
267 Zangani M, Carlsen H, Kielland A, Os A, Hauglin H, Blomhoff R, Munthe LA, Bogen B. Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am J Pathol 2009;174:1358-67. [PMID: 19286564 DOI: 10.2353/ajpath.2009.080700] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
268 Li Z, Kabir I, Tietelman G, Huan C, Fan J, Worgall T, Jiang XC. Sphingolipid de novo biosynthesis is essential for intestine cell survival and barrier function. Cell Death Dis 2018;9:173. [PMID: 29415989 DOI: 10.1038/s41419-017-0214-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
269 Okabayashi S, Kobayashi T, Hibi T. Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns? J Anus Rectum Colon 2020;4:1-13. [PMID: 32002471 DOI: 10.23922/jarc.2019-003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
270 Egawa S, Iijima H, Shinzaki S, Nakajima S, Wang J, Kondo J, Ishii S, Yoshio T, Irie T, Nishida T, Kakiuchi Y, Yasumaru M, Yoshihara H, Kanto T, Tsujii M, Tsuji S, Hayashi N. Upregulation of GRAIL is associated with remission of ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2008;295:G163-9. [PMID: 18467499 DOI: 10.1152/ajpgi.90242.2008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
271 Kennedy AR. Biological Effects of Space Radiation and Development of Effective Countermeasures. Life Sci Space Res (Amst). 2014;1:10-43. [PMID: 25258703 DOI: 10.1016/j.lssr.2014.02.004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 57] [Article Influence: 11.1] [Reference Citation Analysis]
272 Westbrook AM, Szakmary A, Schiestl RH. RETRACTED ARTICLE: Mouse models of intestinal inflammation and cancer. Arch Toxicol 2016;90:2109-30. [DOI: 10.1007/s00204-016-1747-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
273 Shi J. Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:1284-1292. [PMID: 17567878 DOI: 10.1002/ibd.20197] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
274 Chen K, Liu M, Liu Y, Yoshimura T, Shen W, Le Y, Durum S, Gong W, Wang C, Gao JL, Murphy PM, Wang JM. Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest 2013;123:1694-704. [PMID: 23454745 DOI: 10.1172/JCI65569] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 7.6] [Reference Citation Analysis]
275 Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, Domschke W. Recent understanding of IBD pathogenesis: Implications for future therapies: . Inflammatory Bowel Diseases 2006;12:1068-83. [DOI: 10.1097/01.mib.0000235827.21778.d5] [Cited by in Crossref: 161] [Cited by in F6Publishing: 158] [Article Influence: 10.1] [Reference Citation Analysis]
276 Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, Florholmen J. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol. 2007;42:1312-1320. [PMID: 17852866 DOI: 10.1080/00365520701409035] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
277 Haarberg KM, Wymore Brand MJ, Overstreet AMC, Hauck CC, Murphy PA, Hostetter JM, Ramer-Tait AE, Wannemuehler MJ. Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a-/- mice. World J Gastrointest Pharmacol Ther 2015; 6(4): 223-237 [PMID: 26558156 DOI: 10.4292/wjgpt.v6.i4.223] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
278 Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R. Antibiotics for induction and maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2019;2:CD012730. [PMID: 30731030 DOI: 10.1002/14651858.CD012730.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
279 Wan P, Chen H, Guo Y, Bai AP. Advances in treatment of ulcerative colitis with herbs: From bench to bedside. World J Gastroenterol 2014; 20(39): 14099-14104 [PMID: 25339799 DOI: 10.3748/wjg.v20.i39.14099] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
280 Maynard CL, Weaver CT. Intestinal effector T cells in health and disease. Immunity. 2009;31:389-400. [PMID: 19766082 DOI: 10.1016/j.immuni.2009.08.012] [Cited by in Crossref: 128] [Cited by in F6Publishing: 116] [Article Influence: 9.8] [Reference Citation Analysis]
281 Shen P, Zhang Z, He Y, Gu C, Zhu K, Li S, Li Y, Lu X, Liu J, Zhang N, Cao Y. Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage. Life Sci. 2018;196:69-76. [PMID: 29355546 DOI: 10.1016/j.lfs.2018.01.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
282 Zadeh M, Khan MW, Goh YJ, Selle K, Owen JL, Klaenhammer T, Mohamadzadeh M. Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid. J Inflamm (Lond) 2012;9:7. [PMID: 22423982 DOI: 10.1186/1476-9255-9-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
283 La Scaleia R, Morrone S, Stoppacciaro A, Scarpino S, Antonelli M, Bianchi E, Di Nardo G, Oliva S, Viola F, Cucchiara S, Santoni A, Palmieri G, Uccini S. Peripheral and Intestinal CD4+ T Cells With a Regulatory Phenotype in Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 2010;51:563-72. [DOI: 10.1097/mpg.0b013e3181e4d323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
284 Rieder F, Kessler S, Sans M, Fiocchi C. Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. Am J Physiol Gastrointest Liver Physiol. 2012;303:G786-G801. [PMID: 22878121 DOI: 10.1152/ajpgi.00059.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 8.2] [Reference Citation Analysis]
285 Azuma K, Osaki T, Tsuka T, Imagawa T, Okamoto Y, Minami S. Effects of fish scale collagen peptide on an experimental ulcerative colitis mouse model. PharmaNutrition 2014;2:161-8. [DOI: 10.1016/j.phanu.2014.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
286 Azuma K, Osaki T, Ifuku S, Maeda H, Morimoto M, Takashima O, Tsuka T, Imagawa T, Okamoto Y, Saimoto H, Minami S. Suppressive effects of cellulose nanofibers—made from adlay and seaweed—on colon inflammation in an inflammatory bowel-disease model. Bioactive Carbohydrates and Dietary Fibre 2013;2:65-72. [DOI: 10.1016/j.bcdf.2013.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
287 Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis. 2007;8:171-178. [PMID: 17970872 DOI: 10.1111/j.1751-2980.2007.00310.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 6.8] [Reference Citation Analysis]
288 Parra RS, Lopes AH, Carreira EU, Feitosa MR, Cunha FQ, Garcia SB, Cunha TM, da Rocha JJ, Féres O. Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats. Med Gas Res. 2015;5:6. [PMID: 25926972 DOI: 10.1186/s13618-015-0026-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
289 Xue X, Feng T, Yao S, Wolf KJ, Liu CG, Liu X, Elson CO, Cong Y. Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40. J Immunol. 2011;187:5879-5886. [PMID: 22068236 DOI: 10.4049/jimmunol.1100535] [Cited by in Crossref: 100] [Cited by in F6Publishing: 102] [Article Influence: 9.1] [Reference Citation Analysis]
290 Rabizadeh S, Rhee KJ, Wu S, Huso D, Gan CM, Golub JE, Wu X, Zhang M, Sears CL. Enterotoxigenic bacteroides fragilis: a potential instigator of colitis. Inflamm Bowel Dis 2007;13:1475-83. [PMID: 17886290 DOI: 10.1002/ibd.20265] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
291 Seo S, Shin J, Lee W, Rhee YK, Cho C, Hong H, Lee K. Anti-colitis effect of Lactobacillus sakei K040706 via suppression of inflammatory responses in the dextran sulfate sodium-induced colitis mice model. Journal of Functional Foods 2017;29:256-68. [DOI: 10.1016/j.jff.2016.12.045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
292 Wine E, Ossa JC, Gray-Owen SD, Sherman PM. Adherent-invasive Escherichia coli target the epithelial barrier. Gut Microbes 2010;1:80-4. [PMID: 21326914 DOI: 10.4161/gmic.1.2.11142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
293 Rigby RJ, Hunt MR, Scull BP, Simmons JG, Speck KE, Helmrath MA, Lund PK. A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora. Gut. 2009;58:1104-1112. [PMID: 19398439 DOI: 10.1136/gut.2008.157636] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
294 Hartman KG, Bortner JD Jr, Falk GW, Ginsberg GG, Jhala N, Yu J, Martín MG, Rustgi AK, Lynch JP. Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. Exp Biol Med (Maywood) 2014;239:1108-23. [PMID: 24781339 DOI: 10.1177/1535370214529388] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
295 Nitto DD, Sarra M, Pallone F, Monteleone G. Interleukin-21 triggers effector cell responses in the gut. World J Gastroenterol 2010; 16(29): 3638-3641 [PMID: 20677335 DOI: 10.3748/wjg.v16.i29.3638] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
296 Lavoie S, Conway KL, Lassen KG, Jijon HB, Pan H, Chun E, Michaud M, Lang JK, Gallini Comeau CA, Dreyfuss JM, Glickman JN, Vlamakis H, Ananthakrishnan A, Kostic A, Garrett WS, Xavier RJ. The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response. Elife. 2019;8:e39982. [PMID: 30666959 DOI: 10.7554/elife.39982] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
297 Chang JS, Ocvirk S, Berger E, Kisling S, Binder U, Skerra A, Lee AS, Haller D. Endoplasmic reticulum stress response promotes cytotoxic phenotype of CD8αβ+ intraepithelial lymphocytes in a mouse model for Crohn's disease-like ileitis. J Immunol 2012;189:1510-20. [PMID: 22753943 DOI: 10.4049/jimmunol.1200166] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
298 Kuwahara T, Ogura Y, Oshima K, Kurokawa K, Ooka T, Hirakawa H, Itoh T, Nakayama-Imaohji H, Ichimura M, Itoh K. The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing. DNA Res. 2011;18:291-303. [PMID: 21791478 DOI: 10.1093/dnares/dsr022] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
299 Erdmann P, Bruckmueller H, Martin P, Busch D, Haenisch S, Müller J, Wiechowska-kozlowska A, Partecke LI, Heidecke C, Cascorbi I, Drozdzik M, Oswald S. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis. Journal of Pharmaceutical Sciences 2019;108:1035-46. [DOI: 10.1016/j.xphs.2018.09.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
300 Koboziev I, Karlsson F, Zhang S, Grisham MB. Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis 2011;17:1229-45. [PMID: 21312318 DOI: 10.1002/ibd.21557] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
301 Lee JS, Park SY, Thapa D, Choi MK, Chung IM, Park YJ, Yong CS, Choi HG, Kim JA. Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling. Exp Mol Med 2010;42:143-54. [PMID: 20054232 DOI: 10.3858/emm.2010.42.2.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
302 Robinson AM, Gondalia SV, Karpe AV, Eri R, Beale DJ, Morrison PD, Palombo EA, Nurgali K. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016;22:2767-87. [DOI: 10.1097/mib.0000000000000970] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
303 Feng T, Elson CO, Cong Y. Microbiota: dual-faceted player in experimental colitis. Gut Microbes 2010;1:388-91. [PMID: 21468221 DOI: 10.4161/gmic.1.6.13727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
304 Erickson KL, Hubbard NE. Assessing mucosal immunity with new concepts and innovative, time-honored strategies. Nutr Rev 2009;67 Suppl 2:S172-82. [PMID: 19906221 DOI: 10.1111/j.1753-4887.2009.00238.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
305 Braus NA, Elliott DE. Advances in the pathogenesis and treatment of IBD. Clin Immunol. 2009;132:1-9. [PMID: 19321388 DOI: 10.1016/j.clim.2009.02.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
306 Shen P, Zhang Z, Zhu K, Cao H, Liu J, Lu X, Li Y, Jing Y, Yuan X, Fu Y, Cao Y, Zhang N. Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-κB and NLRP3 inflammasome. Biomed Pharmacother 2019;110:786-95. [PMID: 30554117 DOI: 10.1016/j.biopha.2018.12.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
307 Suchodolski JS, Xenoulis PG, Paddock CG, Steiner JM, Jergens AE. Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease. Vet Microbiol. 2010;142:394-400. [PMID: 19959301 DOI: 10.1016/j.vetmic.2009.11.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 7.3] [Reference Citation Analysis]
308 Calderón-gómez E, Bassolas-molina H, Mora-buch R, Dotti I, Planell N, Esteller M, Gallego M, Martí M, Garcia-martín C, Martínez-torró C, Ordás I, Singh S, Panés J, Benítez-ribas D, Salas A. Commensal-Specific CD4+ Cells From Patients With Crohn’s Disease Have a T-Helper 17 Inflammatory Profile. Gastroenterology 2016;151:489-500.e3. [DOI: 10.1053/j.gastro.2016.05.050] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
309 Shin JS, Yun KJ, Chung KS, Seo KH, Park HJ, Cho YW, Baek NI, Jang D, Lee KT. Monotropein isolated from the roots of Morinda officinalis ameliorates proinflammatory mediators in RAW 264.7 macrophages and dextran sulfate sodium (DSS)-induced colitis via NF-κB inactivation. Food Chem Toxicol 2013;53:263-71. [PMID: 23261679 DOI: 10.1016/j.fct.2012.12.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
310 Wu W, He C, Liu C, Cao AT, Xue X, Evans-Marin HL, Sun M, Fang L, Yao S, Pinchuk IV. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD. Gut. 2015;64:1755-1764. [PMID: 25281418 DOI: 10.1136/gutjnl-2014-307980] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 10.6] [Reference Citation Analysis]
311 Palomino-Morales RJ, Oliver J, Gómez-García M, López-Nevot MA, Rodrigo L, Nieto A, Alizadeh BZ, Martín J. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun 2009;10:356-64. [PMID: 19491842 DOI: 10.1038/gene.2009.25] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 4.6] [Reference Citation Analysis]
312 de Bruyn M, Vandooren J, Ugarte-berzal E, Arijs I, Vermeire S, Opdenakker G. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 2016;51:295-358. [DOI: 10.1080/10409238.2016.1199535] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
313 Schmidt EG, Kristensen NN, Claesson MH, Pedersen AE. Enteroantigen-presenting B cells efficiently stimulate CD4(+) T cells in vitro. Inflamm Bowel Dis 2011;17:308-18. [PMID: 20722062 DOI: 10.1002/ibd.21429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
314 Magnusson FC, Liblau RS, von Boehmer H, Pittet MJ, Lee JW, Turley SJ, Khazaie K. Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology. 2008;134:1028-1037. [PMID: 18395084 DOI: 10.1053/j.gastro.2008.01.070] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.5] [Reference Citation Analysis]
315 Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007;13:191-9. [PMID: 17206665 DOI: 10.1002/ibd.20053] [Cited by in Crossref: 121] [Cited by in F6Publishing: 128] [Article Influence: 8.1] [Reference Citation Analysis]
316 Camus M, Esses S, Pariente B, Le Bourhis L, Douay C, Chardiny V, Mocan I, Benlagha K, Clave E, Toubert A, Mayer L, Allez M. Oligoclonal expansions of mucosal T cells in Crohn’s disease predominate in NKG2D-expressing CD4 T cells. Mucosal Immunol 2014;7:325-34. [DOI: 10.1038/mi.2013.51] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
317 Zou Y, Lin J, Li W, Wu Z, He Z, Huang G, Wang J, Ye C, Cheng X, Ding C, Zheng X, Chi H. Huangqin-tang ameliorates dextran sodium sulphate-induced colitis by regulating intestinal epithelial cell homeostasis, inflammation and immune response. Sci Rep. 2016;6:39299. [PMID: 27982094 DOI: 10.1038/srep39299] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
318 Lackeyram D, Young D, Kim CJ, Yang C, Archbold TL, Mine Y, Fan MZ. Interleukin-10 is differentially expressed in the small intestine and the colon experiencing chronic inflammation and ulcerative colitis induced by dextran sodium sulfate in young pigs. Physiol Res 2017;66:147-62. [PMID: 27782738 DOI: 10.33549/physiolres.933259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
319 Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1772-1788. [PMID: 23656897 DOI: 10.1097/mib.0b013e318281f5a3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 56] [Article Influence: 11.5] [Reference Citation Analysis]
320 Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013;24:631-644. [PMID: 24229710 DOI: 10.1016/j.ccr.2013.10.009] [Cited by in Crossref: 268] [Cited by in F6Publishing: 260] [Article Influence: 33.5] [Reference Citation Analysis]
321 Koboziev I, Karlsson F, Grisham MB. Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation. Ann N Y Acad Sci. 2010;1207 Suppl 1:E86-E93. [PMID: 20961311 DOI: 10.1111/j.1749-6632.2010.05711.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
322 Mao JW, Wang YD. Advances in understanding the pathogenesis of mucosal barrier dysfunction in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2010; 18(7): 695-698 [DOI: 10.11569/wcjd.v18.i7.695] [Reference Citation Analysis]
323 Shahanavaj K, Gil-Bazo I, Castiglia M, Bronte G, Passiglia F, Carreca AP, del Pozo JL, Russo A, Peeters M, Rolfo C. Cancer and the microbiome: potential applications as new tumor biomarker. Expert Rev Anticancer Ther 2015;15:317-30. [PMID: 25495037 DOI: 10.1586/14737140.2015.992785] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
324 Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi RH, Wiedmann M, McDonough P, Kim SG, Berg D, Schukken Y, Scherl E, Simpson KW. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 2007;1:403-418. [PMID: 18043660 DOI: 10.1038/ismej.2007.52] [Cited by in Crossref: 414] [Cited by in F6Publishing: 402] [Article Influence: 27.6] [Reference Citation Analysis]
325 Khanna R, Feagan BG. Ustekinumab for the treatment of Crohn’s disease. Immunotherapy. 2013;5:803-815. [PMID: 23902548 DOI: 10.2217/imt.13.81] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
326 Chen DF, Gong BD, Xie Q, Ben QW, Liu J, Yuan YZ. MicroRNA155 is induced in activated CD4+ T cells of TNBS-induced colitis in mice. World J Gastroenterol 2010; 16(7): 854-861 [PMID: 20143464 DOI: 10.3748/wjg.v16.i7.854] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
327 Sugimoto N, Rui T, Yang M, Bharwani S, Handa O, Yoshida N, Yoshikawa T, Kvietys PR. Points of control exerted along the macrophage-endothelial cell-polymorphonuclear neutrophil axis by PECAM-1 in the innate immune response of acute colonic inflammation. J Immunol 2008;181:2145-54. [PMID: 18641353 DOI: 10.4049/jimmunol.181.3.2145] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
328 Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, Wells AD, Hancock WW. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med. 2007;13:1299-1307. [PMID: 17922010 DOI: 10.1038/nm1652] [Cited by in Crossref: 628] [Cited by in F6Publishing: 599] [Article Influence: 41.9] [Reference Citation Analysis]
329 Choi SH, Lee SH, Kim MG, Lee HJ, Kim GB. Lactobacillus plantarum CAU1055 ameliorates inflammation in lipopolysaccharide-induced RAW264.7 cells and a dextran sulfate sodium-induced colitis animal model. J Dairy Sci 2019;102:6718-25. [PMID: 31155246 DOI: 10.3168/jds.2018-16197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
330 Lawrance IC. Ecabet sodium: a potential new agent in the management of distal colitis. J Gastroenterol Hepatol. 2010;25:1182-1184. [PMID: 20594242 DOI: 10.1111/j.1440-1746.2010.06339.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
331 Takebayashi K, Koboziev I, Ostanin DV, Gray L, Karlsson F, Robinson-Jackson SA, Kosloski-Davidson M, Dooley AB, Zhang S, Grisham MB. Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis. Inflamm Bowel Dis 2011;17:268-78. [PMID: 20812332 DOI: 10.1002/ibd.21447] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
332 Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA, Rabizadeh S, Golub JE, Mathews LE, Shin J, Sartor RB, Golenbock D, Hamad AR, Gan CM, Housseau F, Sears CL. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-1718. [PMID: 19188353 DOI: 10.1128/iai.00814-08] [Cited by in Crossref: 175] [Cited by in F6Publishing: 117] [Article Influence: 13.5] [Reference Citation Analysis]
333 Vieira EL, Leonel AJ, Sad AP, Beltrão NR, Costa TF, Ferreira TM, Gomes-santos AC, Faria AM, Peluzio MC, Cara DC, Alvarez-leite JI. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. The Journal of Nutritional Biochemistry 2012;23:430-6. [DOI: 10.1016/j.jnutbio.2011.01.007] [Cited by in Crossref: 158] [Cited by in F6Publishing: 157] [Article Influence: 15.8] [Reference Citation Analysis]
334 Fu J, Wei B, Wen T, Johansson ME, Liu X, Bradford E, Thomsson KA, McGee S, Mansour L, Tong M. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest. 2011;121:1657-1666. [PMID: 21383503 DOI: 10.1172/jci45538] [Cited by in Crossref: 206] [Cited by in F6Publishing: 150] [Article Influence: 18.7] [Reference Citation Analysis]
335 Stankovic B, Dragasevic S, Popovic D, Zukic B, Kotur N, Sokic-milutinovic A, Alempijevic T, Lukic S, Milosavljevic T, Nikcevic G, Pavlovic S. Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence: Genetic variations in prediction of IBD. Journal of Digestive Diseases 2015;16:723-33. [DOI: 10.1111/1751-2980.12281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
336 Fiebiger U, Bereswill S, Heimesaat MM. Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) 2016;6:253-71. [PMID: 27980855 DOI: 10.1556/1886.2016.00036] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 11.2] [Reference Citation Analysis]
337 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Reference Citation Analysis]
338 Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, Hudcovic T, Vannucci L, Tučková L, Rossmann P, Hrnčíř T, Kverka M, Zákostelská Z, Klimešová K, Přibylová J, Bártová J, Sanchez D, Fundová P, Borovská D, Srůtková D, Zídek Z, Schwarzer M, Drastich P, Funda DP. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011;8:110-20. [PMID: 21278760 DOI: 10.1038/cmi.2010.67] [Cited by in Crossref: 408] [Cited by in F6Publishing: 365] [Article Influence: 37.1] [Reference Citation Analysis]
339 Matharu KS, Mizoguchi E, Cotoner CA, Nguyen DD, Mingle B, Iweala OI, McBee ME, Stefka AT, Prioult G, Haigis KM, Bhan AK, Snapper SB, Murakami H, Schauer DB, Reinecker HC, Mizoguchi A, Nagler CR. Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice. Gastroenterology 2009;137:1380-90.e1-3. [PMID: 19596011 DOI: 10.1053/j.gastro.2009.07.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
340 Ding S, Blue RE, Morgan DR, Lund PK. Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models. Inflamm Bowel Dis 2014;20:363-77. [PMID: 24374874 DOI: 10.1097/01.MIB.0000440612.98950.79] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
341 Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. 2008;125:145-153. [PMID: 18798918 DOI: 10.1111/j.1365-2567.2008.02939.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 6.8] [Reference Citation Analysis]
342 Porter CK, Riddle MS, Gutierrez RL, Princen F, Strauss R, Telesco SE, Torres J, Choung RS, Laird RM, Leon F, Colombel JF, Murray JA; PREDICTS study team. Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics. Contemp Clin Trials Commun 2019;14:100345. [PMID: 30989149 DOI: 10.1016/j.conctc.2019.100345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
343 Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012;30:149-73. [PMID: 22224779 DOI: 10.1146/annurev-immunol-020711-075001] [Cited by in Crossref: 236] [Cited by in F6Publishing: 233] [Article Influence: 23.6] [Reference Citation Analysis]
344 Wang L, Tang H, Wang C, Hu Y, Wang S, Shen L. Aquaporin 4 deficiency alleviates experimental colitis in mice. FASEB J 2019;33:8935-44. [PMID: 31034776 DOI: 10.1096/fj.201802769RR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
345 Singhal S, Dian D, Keshavarzian A, Fogg L, Fields JZ, Farhadi A. The role of oral hygiene in inflammatory bowel disease. Dig Dis Sci 2011;56:170-5. [PMID: 20458622 DOI: 10.1007/s10620-010-1263-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
346 Øyri SF, Műzes G, Sipos F. Dysbiotic gut microbiome: A key element of Crohn's disease. Comp Immunol Microbiol Infect Dis 2015;43:36-49. [PMID: 26616659 DOI: 10.1016/j.cimid.2015.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
347 Palmer MT, Weaver CT. Autoimmunity: increasing suspects in the CD4+ T cell lineup. Nat Immunol 2010;11:36-40. [PMID: 20016508 DOI: 10.1038/ni.1802] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]